1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biosimilar Revenue
1.4 Market Analysis by Type
1.4.1 Global Biosimilar Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human Growth Hormones
1.4.3 Monoclonal Antibodies
1.4.4 Insulin
1.4.5 Peptides
1.4.6 Erythropoietin
1.4.7 Others
1.5 Market by Application
1.5.1 Global Biosimilar Market Share by Application: 2021-2026
1.5.2 Oncology
1.5.3 Chronic and Autoimmune Diseases
1.5.4 Growth Hormone Deficiency
1.5.5 Infectious Diseases
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Biosimilar Market
1.8.1 Global Biosimilar Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Biosimilar Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Biosimilar Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Biosimilar Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Biosimilar Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Biosimilar Sales Volume Market Share by Region (2015-2020)
3.2 Global Biosimilar Sales Revenue Market Share by Region (2015-2020)
3.3 North America Biosimilar Sales Volume
3.3.1 North America Biosimilar Sales Volume Growth Rate (2015-2020)
3.3.2 North America Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Biosimilar Sales Volume
3.4.1 East Asia Biosimilar Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Biosimilar Sales Volume (2015-2020)
3.5.1 Europe Biosimilar Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Biosimilar Sales Volume (2015-2020)
3.6.1 South Asia Biosimilar Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Biosimilar Sales Volume (2015-2020)
3.7.1 Southeast Asia Biosimilar Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Biosimilar Sales Volume (2015-2020)
3.8.1 Middle East Biosimilar Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Biosimilar Sales Volume (2015-2020)
3.9.1 Africa Biosimilar Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Biosimilar Sales Volume (2015-2020)
3.10.1 Oceania Biosimilar Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Biosimilar Sales Volume (2015-2020)
3.11.1 South America Biosimilar Sales Volume Growth Rate (2015-2020)
3.11.2 South America Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Biosimilar Sales Volume (2015-2020)
3.12.1 Rest of the World Biosimilar Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Biosimilar Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Biosimilar Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Biosimilar Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Biosimilar Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Biosimilar Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Biosimilar Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Biosimilar Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Biosimilar Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Biosimilar Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Biosimilar Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Biosimilar Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Biosimilar Sales Volume Market Share by Type (2015-2020)
14.2 Global Biosimilar Sales Revenue Market Share by Type (2015-2020)
14.3 Global Biosimilar Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Biosimilar Consumption Volume by Application (2015-2020)
15.2 Global Biosimilar Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Biosimilar Business
16.1 Allergan plc
16.1.1 Allergan plc Company Profile
16.1.2 Allergan plc Biosimilar Product Specification
16.1.3 Allergan plc Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Dr. Reddys Laboratories
16.2.1 Dr. Reddys Laboratories Company Profile
16.2.2 Dr. Reddys Laboratories Biosimilar Product Specification
16.2.3 Dr. Reddys Laboratories Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 BioXpress Therapeutics
16.3.1 BioXpress Therapeutics Company Profile
16.3.2 BioXpress Therapeutics Biosimilar Product Specification
16.3.3 BioXpress Therapeutics Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 BIOCAD
16.4.1 BIOCAD Company Profile
16.4.2 BIOCAD Biosimilar Product Specification
16.4.3 BIOCAD Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Coherus BioSciences
16.5.1 Coherus BioSciences Company Profile
16.5.2 Coherus BioSciences Biosimilar Product Specification
16.5.3 Coherus BioSciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Biocon
16.6.1 Biocon Company Profile
16.6.2 Biocon Biosimilar Product Specification
16.6.3 Biocon Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Intas Pharmaceuticals Limited
16.7.1 Intas Pharmaceuticals Limited Company Profile
16.7.2 Intas Pharmaceuticals Limited Biosimilar Product Specification
16.7.3 Intas Pharmaceuticals Limited Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Celltrion
16.8.1 Celltrion Company Profile
16.8.2 Celltrion Biosimilar Product Specification
16.8.3 Celltrion Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Boehringer Ingelheim
16.9.1 Boehringer Ingelheim Company Profile
16.9.2 Boehringer Ingelheim Biosimilar Product Specification
16.9.3 Boehringer Ingelheim Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Genor BioPharma
16.10.1 Genor BioPharma Company Profile
16.10.2 Genor BioPharma Biosimilar Product Specification
16.10.3 Genor BioPharma Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Novartis
16.11.1 Novartis Company Profile
16.11.2 Novartis Biosimilar Product Specification
16.11.3 Novartis Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Pfizer
16.12.1 Pfizer Company Profile
16.12.2 Pfizer Biosimilar Product Specification
16.12.3 Pfizer Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Reliance Life Sciences
16.13.1 Reliance Life Sciences Company Profile
16.13.2 Reliance Life Sciences Biosimilar Product Specification
16.13.3 Reliance Life Sciences Biosimilar Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Biosimilar Manufacturing Cost Analysis
17.1 Biosimilar Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Biosimilar
17.4 Biosimilar Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Biosimilar Distributors List
18.3 Biosimilar Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Biosimilar (2021-2026)
20.2 Global Forecasted Revenue of Biosimilar (2021-2026)
20.3 Global Forecasted Price of Biosimilar (2015-2026)
20.4 Global Forecasted Production of Biosimilar by Region (2021-2026)
20.4.1 North America Biosimilar Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Biosimilar Production, Revenue Forecast (2021-2026)
20.4.3 Europe Biosimilar Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Biosimilar Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Biosimilar Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Biosimilar Production, Revenue Forecast (2021-2026)
20.4.7 Africa Biosimilar Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Biosimilar Production, Revenue Forecast (2021-2026)
20.4.9 South America Biosimilar Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Biosimilar Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Biosimilar by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Biosimilar by Country
21.2 East Asia Market Forecasted Consumption of Biosimilar by Country
21.3 Europe Market Forecasted Consumption of Biosimilar by Countriy
21.4 South Asia Forecasted Consumption of Biosimilar by Country
21.5 Southeast Asia Forecasted Consumption of Biosimilar by Country
21.6 Middle East Forecasted Consumption of Biosimilar by Country
21.7 Africa Forecasted Consumption of Biosimilar by Country
21.8 Oceania Forecasted Consumption of Biosimilar by Country
21.9 South America Forecasted Consumption of Biosimilar by Country
21.10 Rest of the world Forecasted Consumption of Biosimilar by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer